# Stanford Health Care account plan

> Stanford Health Care is the not-for-profit adult academic health system of Stanford Medicine in the Bay Area, with $9,465,504 thousand of FY2025 revenue.

## At a glance

Stanford Health Care (SHC) is a California not-for-profit academic health system that operates Stanford Hospital and a cancer center in Palo Alto, plus outpatient clinics across the San Francisco Bay Area. With Lucile Salter Packard Children's Hospital it is the clinical setting of the Stanford School of Medicine, and the Board of Trustees of Stanford University is its sole corporate member. It provides quaternary and specialty adult care in cardiac care, cancer, transplantation, neurosciences and orthopedics. In FY2025 (year ended August 31, 2025) total operating revenues and other support were $9,465,504 thousand and income from operations was $472,669 thousand. Activity included 37,555 discharges, 48,944 surgeries and 112,058 emergency department visits.

## Business units

- **Stanford Health Care (Stanford Hospital, cancer center, clinics)** (about 88% of FY2025 pre-elimination operating revenue ($8,453,628 thousand)): The parent entity runs Stanford Hospital, the Palo Alto cancer center and clinics, and carries the group's operating profit, with income from operations of $534,489 thousand in FY2025. It also holds the investment portfolio and the 300P Renewal of the original hospital.
- **Stanford Health Care Tri-Valley** (about 6.5% of FY2025 pre-elimination operating revenue ($622,537 thousand)): A 242 licensed bed community hospital system in Pleasanton, Livermore and Dublin in the East Bay, inpatient and outpatient. It earned $15,516 thousand from operations in FY2025 and owns an ambulatory surgery center targeted to open in 2027.
- **Stanford Medicine Partners (University HealthCare Alliance)** (about 3.5% of FY2025 pre-elimination operating revenue ($338,316 thousand)): A physician medical foundation building a community clinical delivery network for the School of Medicine and SHC, holding capitated HMO agreements. It lost $86,687 thousand from operations in FY2025, funded by SHC, and in April 2025 formed Stanford Community Imaging with the School of Medicine to build imaging centers.
- **Stanford Blood Center** (about 1.2% of FY2025 pre-elimination operating revenue ($117,550 thousand)): A community blood center selling blood products and testing services to hospitals, clinics and companies, with income from operations of $12,528 thousand in FY2025.
- **Captive insurance (SUMIT Holding International, PEAC)**: SUMIT, a Bermuda captive owned through SHI (82% SHC, 18% LPCH), insures SHC, Tri-Valley and the blood center for professional, general and cyber liability; PEAC covers Stanford Medicine Partners and other affiliates.
- **Oncology joint ventures (SEROC, ERTS, OSV)**: Radiation oncology ventures held 60% by SHC with Doctors Medical Center of Modesto and with Sutter, including the Sutter Stanford Cancer Collaborative in the Eden area and a venture formed to expand cancer care in the East Bay.
- **CareCounsel**: A wholly owned provider of employer-sponsored health advocacy and health care assistance services for employees, retirees and their families.

## Strategic priorities

- **Seismic renewal of the original hospital**: The 300P Renewal, at an estimated cost of approximately $1.6 billion and including 57 new beds in extension towers, must move all inpatients out of 1959-era buildings before the January 1, 2030 seismic deadline; $705 million was recorded to property and equipment as of August 31, 2025.
- **Cancer care capacity**: A new cancer center in Redwood City responds to cancer patient volumes that the CEO says doubled over the last 10 years, combining research and care next to a new ultracompact proton therapy facility.
- **Agentic AI on the health record**: Stanford built ChatEHR so physicians can query whole patient records with multiple large language models, used to find missed diagnoses and match patients to clinical trials in real time.
- **Back-office automation and cost**: The CEO calls cost one of the biggest challenges, judges AI investments on savings, sees benefits in back-office operations and names billing and collections as the most outdated part of healthcare.
- **Oncology and neurosciences focus**: Oncology and neurosciences are the current priority areas; the Stanford Medicine Catalyst accelerator receives more than 100 ideas a year.

## Latest results

For the nine months ended May 31, 2026 (Q3 of FY2026, unaudited), total operating revenues and other support were $7,612,533 thousand versus $7,135,954 thousand a year earlier, and income from operations rose to $436,322 thousand from $393,048 thousand. Salaries and benefits reached $3,390,646 thousand and purchased services $1,804,984 thousand, the largest cost lines. Volumes rose: discharges 28,931 versus 27,792, other outpatient visits 954,003 versus 880,068 and surgeries 37,223 versus 36,623. Purchases of property and equipment were $494,896 thousand, already above the full FY2025 figure. The disclosure gives no guidance.

## Investments and deals

- **300P Renewal**: Hospital renovation and extension towers estimated at approximately $1.6 billion; renovations on the E Pod units and groundbreaking for 57 beds began in Summer 2024, followed by the F Pod.
- **Capital spending**: Purchases of property and equipment were $489,076 thousand in FY2025 and $494,896 thousand in the first nine months of FY2026; contractual obligations total approximately $708,963 thousand for renovations and capital projects.
- **2025 bond issues**: In June 2025 CHFFA issued the 2025 Series A ($149,580 thousand, a refunding) and 2025 Series B ($266,540 thousand), reimbursing the 300P Renewal and Redwood City Medical Office Building projects.
- **Redwood City cancer center and imaging network**: A new cancer center in Redwood City alongside a proton therapy facility, and Stanford Community Imaging, formed April 2, 2025 to build a network of imaging centers.
- **IT outsourcing extension**: An agreement with a global technology services and outsourcing company was extended through March 31, 2029, with expected spend of approximately $50,993 thousand.

## Challenges and risks

- **Seismic deadline**: Because of construction delays, the pandemic and elevated census, the bed tower work will miss the January 1, 2026 interim seismic deadline; SHC is coordinating the schedule with HCAI ahead of the January 1, 2030 deadline.
- **Medicaid and supplemental funding**: OBBBA provisions affect Medicaid funding; Medi-Cal revenue fell to $63,164 thousand in FY2025 from $255,202 thousand as Quality Assurance Fee supplemental payments dropped.
- **University excise tax**: The University's net investment income excise tax rises from 1.4% to 8% from fiscal 2027; SHC recorded $84 million of excise tax expense in FY2025.
- **Labor cost and unions**: Salaries and benefits were $4,225,659 thousand in FY2025, the CEO says about 60% of US health system costs are labour, and approximately 39% of employees are covered by collective bargaining.
- **Security and privacy**: Information security and privacy incidents are named among the system's risks.

## What leadership says

> "Cost is one of the biggest challenges we face, particularly in one of the most expensive regions in the world." — David Entwistle, President and Chief Executive Officer, Investment Reports interview, published July 1, 2026

> "What feels most outdated is billing and collections." — David Entwistle, President and Chief Executive Officer, Investment Reports interview, published July 1, 2026

> "Transparency and trust are absolutely key." — Karl Hightower, Vice President and Chief Data and Analytics Officer, CDO Magazine two-part interview, June 2025


## Where a supplier can help

- **Revenue cycle automation**: Tied to the back-office automation priority and the labor cost challenge: the CEO names billing, collections, referrals and pre-authorisations as manual and outdated, and AI investments are judged on savings.
- **Data platforms and engineering**: Tied to the agentic AI priority: the data organisation keeps model and clinical innovation in-house but uses partners for moving and cleaning data, platforms and agent orchestration, screened through published governance.
- **Construction and clinical fit-out**: Tied to the 300P Renewal and seismic deadline: approximately $708,963 thousand of contracted renovation and capital work and new beds create demand for construction, equipment and project services.
- **Oncology capacity build-out**: Tied to the Redwood City cancer center and imaging network investments: new sites need equipment, IT, staffing and operations support.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [Annual Disclosure Report for the Fiscal Year Ended August 31, 2025 (with Audited Consolidated Financial Statements)](https://stanfordhealthcare.org/content/dam/SHC/about-us/bondholder-information/docs/FY25-Annual-Disclosure-Report---with-AFS.pdf)

Annual report · 2025-12-10

- Stanford Health Care (SHC) is a California not-for-profit academic health system: it operates Stanford Hospital and a cancer center in Palo Alto plus outpatient clinics across the San Francisco Bay Area; the Board of Trustees of Stanford University is its sole corporate member, and with Lucile Salter Packard Children's Hospital (LPCH) it is the clinical setting of the Stanford School of Medicine (SoM).
- FY2025 (year ended August 31, 2025): total operating revenues and other support of $9,465,504 thousand (FY2024: $8,952,424 thousand), of which net patient service revenue $9,165,371 thousand; income from operations $472,669 thousand (FY2024: $543,759 thousand); excess of revenues over expenses $1,172,481 thousand.
- Cost base: total operating expenses $8,992,835 thousand, led by salaries and benefits ($4,225,659 thousand), purchased services ($2,246,821 thousand, including $1,594,367 thousand of SoM physician services under the Professional Services Agreement) and supplies ($1,573,643 thousand).
- Payor mix: Managed Care discounted fee-for-service $5,887,315 thousand, Medicare $1,538,580 thousand, Medicare Managed Care $694,558 thousand, Medi-Cal Managed Care $612,737 thousand; Blue Cross is 18% of net patient receivables.
- Activity: 37,555 discharges, 48,944 surgeries, 112,058 emergency department visits and 1,174,033 other outpatient visits; case mix index 2.69.
- Balance sheet: total assets $14,327,169 thousand; total liquid assets $7,289,505 thousand and 305 days cash on hand; total debt $2,810,911 thousand, 24.3% of capitalization; capex (purchases of property and equipment) $489,076 thousand.
- Biggest project: the 300P Renewal of the original hospital (estimated cost approximately $1.6 billion), including 57 new beds in extension towers, to move all inpatients out of 1959-era buildings before the January 1, 2030 seismic deadline; the January 1, 2026 interim deadline will be missed.
- Risks named: OBBBA changes to Medicaid funding, an increase to 8% in the University's net investment income excise tax (SHC recorded $84 million of excise tax expense), information security and privacy incidents, and about 39% of employees under collective bargaining.

### [Quarterly Financial Disclosure for the Nine-Month Period Ended May 31, 2026 (Q3 FY2026, unaudited)](https://stanfordhealthcare.org/content/dam/SHC/about-us/bondholder-information/docs/Continuing-Disclosure-Q3-FY-26.pdf)

Interim report · 2026-07-08

- Unaudited quarterly disclosure for the nine months ended May 31, 2026 (Q3 of FY2026), prepared by management for bondholders.
- Total operating revenues and other support of $7,612,533 thousand vs $7,135,954 thousand a year earlier; net patient service revenue $7,430,244 thousand vs $6,926,090 thousand.
- Income from operations $436,322 thousand vs $393,048 thousand; total operating expenses $7,176,211 thousand, salaries and benefits $3,390,646 thousand.
- Excess of revenues over expenses $1,291,606 thousand vs $829,174 thousand, lifted by interest and investment income ($477,864 thousand) and University managed pools ($373,946 thousand).
- Cash provided by operating activities $763,480 thousand; purchases of property and equipment $494,896 thousand vs $358,094 thousand, already above the full FY2025 figure.
- Volumes up: discharges 28,931 (27,792), other outpatient visits 954,003 (880,068), surgeries 37,223 (36,623); acute average daily census 699.6.
- Total assets $15,423,417 thousand, net assets $10,124,286 thousand; cash and cash equivalents $610,628 thousand; no short-term borrowing outstanding (vs $50,000 thousand a year earlier).

### [David Entwistle, President & CEO, Stanford Health Care - Investment Reports interview](https://www.investmentreports.co/interview/david-entwistle-2405)

Executive talk · David Entwistle, President and Chief Executive Officer · 2026-07-01

- Interview of David Entwistle, President and CEO of Stanford Health Care, published by Investment Reports on 01 July 2026.
- Says the biggest change in his nearly 30-year career is transparency and the ability to use data, now used for research, patient summaries and enabling clinicians.
- A new cancer center in Redwood City responds to cancer patient volumes that "doubled over the last 10 years" and will combine discovery, research and care (tumour-infiltrating lymphocytes, stem cell, gene and immunotherapies), next to a new ultracompact proton therapy facility.
- Most excited by agentic AI; Stanford built ChatEHR, letting physicians query whole patient records with multiple large language models, used to find missed diagnoses and match patients to clinical trials in real time.
- Prioritisation: Stanford Medicine Catalyst receives more than 100 ideas a year; oncology and neurosciences are current priority areas.
- Cost is "one of the biggest challenges"; AI investments are judged on savings, with meaningful benefits now seen in back-office operations.
- Calls billing and collections the most outdated part of healthcare; about 60% of US health system costs are labour, a target for automation.

### [CDAO Karl Hightower on Stanford Health Care's Plan to Scale AI Without Losing Trust (CDO Magazine, two-part interview)](https://www.cdomagazine.tech/data-privacy/cdao-karl-hightower-on-stanford-health-cares-plan-to-scale-ai-without-losing-trust)

Executive talk · Karl Hightower, Vice President and Chief Data and Analytics Officer · 2025-06-18

- Two-part interview (CDO Magazine with EY's Sezin Palmer, June 2025) of Karl Hightower, then Vice President and Chief Data and Analytics Officer at Stanford Health Care and the School of Medicine.
- Immediate AI opportunity: remove clinicians' typing and screen time with ambient, voice-to-text tools that summarise a patient's whole history for the visit.
- Longer-term opportunity: personalisation, a "simulation of you" to predict the best treatment or drug options.
- Trust and transparency are "absolutely key"; Stanford uses openly published governance and frameworks such as FURM and MedHELM, and an ethics and governance board for questions like facial recognition.
- His focus is decisioning: automate data preparation so people can make decisions and act, without overengineering.
- Build-and-partner model: Stanford's internal talent does the high-value work; partners take on moving and cleaning data and provide platforms, and are invited to co-innovate in a safe environment, including for agentic AI orchestration.
- Wants regulators, including the FDA, to ease enough to let new ideas reach patients.

## Questions about Stanford Health Care

### What does Stanford Health Care do?

It operates Stanford Hospital, a cancer center in Palo Alto and outpatient clinics across the Bay Area, providing quaternary and specialty adult care, and with Lucile Packard Children's Hospital it is the clinical setting of the Stanford School of Medicine.

### What is Stanford Health Care's revenue?

Total operating revenues and other support were $9,465,504 thousand in FY2025 (year ended August 31, 2025), with income from operations of $472,669 thousand. For the nine months to May 31, 2026 they were $7,612,533 thousand.

### What are Stanford Health Care's priorities?

The seismic renewal of its original hospital before 2030, cancer capacity in Redwood City, agentic AI on the health record and automation of back-office work to control cost.

### Who leads Stanford Health Care?

David Entwistle is President and CEO; Linda Hoff is Chief Financial Officer.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
